CSIMarket
 


Aratana Therapeutics, Inc.  (PETX)
Other Ticker:  
 
 

PETX's Net Cash Flow Growth by Quarter and Year

Aratana Therapeutics,'s Net Cash Flow results by quarter and year




PETX Net Cash Flow (in millions $) FY 2019 FY 2018 FY 2017 FY 2016
IV Quarter December - 0.00 18.46 -7.91
III Quarter September - 0.00 -9.97 94.95
II Quarter June - 0.00 11.29 -12.94
I Quarter March 0.00 0.00 -19.78 13.23
FY   0.00 0.00 0.00 87.33



PETX Net Cash Flow first quarter 2019 Y/Y Growth Comment
Aratana Therapeutics, Inc. in the first quarter 2019 recorded net cash outflow of $ 0.00 millions.

According to the results reported in the first quarter 2019, Aratana Therapeutics, Inc. achieved the best Net Cash Flow growth in Major Pharmaceutical Preparations industry. While Aratana Therapeutics, Inc.' s Net Cash Flow no change of % ranks overall at the positon no. in the first quarter 2019.




PETX Net Cash Flow ( Y/Y Growth %) 2019
2018 2017 2016
IV Quarter December - - - -
III Quarter September - - - -
II Quarter June - - - -
I Quarter March - - - -
FY   - - - -

Financial Statements
Aratana Therapeutics,'s first quarter 2019 Net Cash Flow $ 0.00 millions PETX's Income Statement
Aratana Therapeutics,'s first quarter 2018 Net Cash Flow $ 0.00 millions Quarterly PETX's Income Statement
New: More PETX's historic Net Cash Flow Growth >>


PETX Net Cash Flow (Quarter on Quarter Growth %)

2019
2018 2017 2016
IV Quarter December - - - -
III Quarter September - - - -
II Quarter June - - - -
I Quarter March - - - 1322.58 %
FY (Year on Year)   - - - -




Net Cash Flow first quarter 2019 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #

Net Cash Flow Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 
Net Cash Flow first quarter 2019 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #
Net Cash Flow Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 

Net Cash Flow by Quarter for the Fiscal Years 2016, 2017, 2018, 2019

Aratana Therapeutics,'s Q/Q Net Cash Flow Growth


Net Cash Flow Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


PETX's I. Quarter Q/Q Net Cash Flow Comment


Net Cash Flow Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #
Net Cash Flow Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #
Net Cash Flow Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


PETX's I. Quarter Q/Q Net Cash Flow Comment


Aratana Therapeutics,'s 12 Months Net Cash Flow Growth Year on Year


Net Cash Flow TTM Growth

12 Months Ending
(Mar 31 2019)
12 Months Ending
(Dec 31 2018)
12 Months Ending
(Sep 30 2018)
12 Months Ending
(Jun 30 2018)
12 Months Ending
(Mar 31 2018)
Cumulative Net Cash Flow 12 Months Ending $ 0.00 $ 0.00 $ 0.00 $ 0.00 $ 0.00
Y / Y Net Cash Flow Growth (TTM) - - - - -
Year on Year Net Cash Flow Growth Overall Ranking # # # # #
Seqeuential Net Cash Flow Change (TTM) - - - - -
Seq. Net Cash Flow Growth (TTM) Overall Ranking # # # # #




Cumulative Net Cash Flow growth Comment
In the Mar 31 2019 period, Aratana Therapeutics,'s cumulative trailing twelve month Net Cash Flow remained unchanged compare to the same period a year ago.

Aratana Therapeutics, Inc. achieved highest trailing twelve month year on year Net Cash Flow growth. While overall Net Cash Flow growth ranking, remained unchanged compare to the previous quarter at no. .

Net Cash Flow TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 

Net Cash Flow TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #

Net Cash Flow TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Net Cash Flow TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #
Cumulative Net Cash Flow growth Comment
In the Mar 31 2019 period, Aratana Therapeutics,'s cumulative trailing twelve month Net Cash Flow remained unchanged compare to the same period a year ago.

Aratana Therapeutics, Inc. achieved highest trailing twelve month year on year Net Cash Flow growth. While overall Net Cash Flow growth ranking, remained unchanged compare to the previous quarter at no. .

Net Cash Flow TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 


Net Cash Flow TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #

Net Cash Flow TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Net Cash Flow TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #




Other Net Cash Flow Growth
Major Pharmaceutical Preparations Industry Net Cash Flow Growth Trends and Statistics
Healthcare Sector Net Cash Flow Growth Statistics
Net Cash Flow Growth Trends for overall market
PETX's Net Cash Flow Growth Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Net Cash Flow Growth
Lowest Ranking Net Cash Flow Growth
Net Cash Flow Growth for PETX's Competitors
Net Cash Flow Growth for Aratana Therapeutics,'s Suppliers
Net Cash Flow Growth for PETX's Customers

You may also want to know
PETX's Annual Growth Rates PETX's Profitability Ratios PETX's Asset Turnover Ratio PETX's Dividend Growth
PETX's Roe PETX's Valuation Ratios PETX's Financial Strength Ratios PETX's Dividend Payout Ratio
PETX's Roa PETX's Inventory Turnover Ratio PETX's Growth Rates PETX's Dividend Comparisons



Companies with similar Net Cash Flow no change for the quarter ending Mar 31 2019 within Healthcare SectorY/Y Change %Net Cash Flow for the quarter ending Mar 31 2019
Reliv International Inc-3.20%$ -3.202 millions
Grapefruit Usa Inc -11.14%$ -11.137 millions
Tg Therapeutics Inc -14.46%$ -14.458 millions
Biospecifics Technologies Corp-15.39%$ -15.389 millions
Anika Therapeutics Inc -24.22%$ -24.224 millions
Volitionrx Limited-33.90%$ -33.904 millions
Vystar Corporation-37.35%$ -37.348 millions
Regenerx Biopharmaceuticals inc -42.67%$ -42.665 millions
United Therapeutics Corporation-46.66%$ -46.661 millions
Hill rom Holdings Inc -47.17%$ -47.170 millions
Corindus Vascular Robotics, Inc.-47.49%$ -47.492 millions
9 Meters Biopharma Inc -54.31%$ -54.315 millions
Teladoc Health Inc -54.50%$ -54.500 millions
Arca Biopharma Inc -58.81%$ -58.810 millions
Biogen Inc -59.80%$ -59.804 millions
Cellular Biomedicine Group Inc -61.54%$ -61.544 millions
Pacific Health Care Organization Inc -66.80%$ -66.802 millions
Catalent Inc -67.74%$ -67.742 millions
Moleculin Biotech Inc -69.48%$ -69.481 millions
Lifeloc Technologies Inc -70.66%$ -70.661 millions
Innovage Holding Corp -79.19%$ -79.190 millions
Quidelortho Corp-79.85%$ -79.851 millions
Vyne Therapeutics Inc -81.78%$ -81.780 millions
Agios Pharmaceuticals Inc -87.41%$ -87.415 millions
Conformis inc -88.67%$ -88.667 millions
Kura Oncology Inc -89.00%$ -89.002 millions
Accelerate Diagnostics Inc -90.80%$ -90.798 millions
Xtant Medical Holdings Inc -90.95%$ -90.953 millions
Hca Healthcare Inc -91.81%$ -91.808 millions
Guided Therapeutics Inc -92.00%$ -92.000 millions




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com